Beam Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Beam Therapeutics Inc. (BEAM) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$29.53M.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $31.86M.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$59.00K, a 100.76% decline year-over-year.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.63M.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$4.51M, a 184.33% decline from fiscal 2024.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $5.35M, a 19.19% decline from fiscal 2023.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $6.62M, a 14.63% decline from fiscal 2022.
- Beam Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $7.75M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$29.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.33M 10-Q · filed 2026-08-04 | $2.27M derived: sum of 3 quarters · filed 2026-08-04 | $644.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $31.86M 10-Q · filed 2026-05-07 | $31.80M derived: sum of 2 quarters · filed 2026-05-07 | $30.18M derived: sum of 3 quarters · filed 2026-05-07 | $27.40M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.68M derived: sum of 2 quarters · filed 2026-02-24 | -$4.46M derived: sum of 3 quarters · filed 2026-08-04 | -$4.51M 10-K · filed 2026-02-24 | |
| 2025-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.40M derived: sum of 2 quarters · filed 2026-08-04 | -$4.45M 10-Q · filed 2025-11-04 | $3.35M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.83M 10-Q · filed 2026-08-04 | $4.98M derived: sum of 3 quarters · filed 2026-08-04 | $3.24M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$49.00K 10-Q · filed 2026-05-07 | $7.76M derived: sum of 2 quarters · filed 2026-05-07 | $6.01M derived: sum of 3 quarters · filed 2026-05-07 | -$232.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.06M derived: sum of 2 quarters · filed 2026-02-24 | -$183.00K derived: sum of 3 quarters · filed 2026-02-24 | $5.35M 10-K · filed 2026-02-24 | |
| 2024-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$7.99M derived: sum of 2 quarters · filed 2025-11-04 | -$2.46M 10-Q · filed 2025-11-04 | -$5.88M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | -$6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$714.00K 10-Q · filed 2025-08-05 | -$4.14M derived: sum of 3 quarters · filed 2026-02-24 | -$571.00K derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $5.53M 10-Q · filed 2025-05-06 | $2.11M derived: sum of 2 quarters · filed 2026-02-24 | $5.67M derived: sum of 3 quarters · filed 2026-02-24 | $3.75M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $143.00K derived: sum of 2 quarters · filed 2026-02-24 | -$1.79M derived: sum of 3 quarters · filed 2026-02-24 | $6.62M 10-K · filed 2026-02-24 | $6.47M 10-K · filed 2024-02-27 |
| 2023-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.64M derived: sum of 2 quarters · filed 2024-11-05 | $10.04M 10-Q · filed 2024-11-05 | $10.60M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $6.48M 10-Q · filed 2024-08-06 | $7.04M derived: sum of 3 quarters · filed 2025-02-25 | $7.27M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $8.40M 10-Q · filed 2024-05-07 | $8.97M derived: sum of 2 quarters · filed 2025-02-25 | $9.20M derived: sum of 3 quarters · filed 2025-02-25 | $6.97M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $796.00K derived: sum of 2 quarters · filed 2025-02-25 | -$1.43M derived: sum of 3 quarters · filed 2025-02-25 | $7.75M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.99M derived: sum of 2 quarters · filed 2023-11-08 | $7.19M 10-Q · filed 2023-11-08 | $7.18M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $6.96M 10-Q · filed 2023-08-08 | $6.94M derived: sum of 3 quarters · filed 2024-02-27 | $3.10M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $9.19M 10-Q · filed 2023-05-10 | $9.17M derived: sum of 2 quarters · filed 2024-02-27 | $5.33M derived: sum of 3 quarters · filed 2024-02-27 | $6.07M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$3.85M derived: sum of 2 quarters · filed 2024-02-27 | -$3.11M derived: sum of 3 quarters · filed 2024-02-27 | -$746.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$3.10M derived: sum of 2 quarters · filed 2022-11-07 | -$733.00K 10-Q · filed 2022-11-07 | $1.33M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.11M 10-Q · filed 2022-08-09 | $5.17M derived: sum of 3 quarters · filed 2023-02-28 | $4.62M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $2.37M 10-Q · filed 2022-05-09 | $4.42M derived: sum of 2 quarters · filed 2023-02-28 | $3.88M derived: sum of 3 quarters · filed 2023-02-28 | $4.53M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.51M derived: sum of 2 quarters · filed 2023-02-28 | $2.17M derived: sum of 3 quarters · filed 2023-02-28 | $5.73M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $108.00K derived: sum of 2 quarters · filed 2021-11-08 | $3.67M 10-Q · filed 2021-11-08 | $2.87M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $4.21M 10-Q · filed 2021-08-10 | $3.42M derived: sum of 3 quarters · filed 2022-02-28 | $4.68M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $3.56M 10-Q · filed 2021-05-11 | $2.76M derived: sum of 2 quarters · filed 2022-02-28 | $4.02M derived: sum of 3 quarters · filed 2022-02-28 | $4.39M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | -$797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $461.00K derived: sum of 2 quarters · filed 2022-02-28 | $833.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.26M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.63M derived: sum of 2 quarters · filed 2020-11-10 | $2.06M 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $797.00K 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | $425.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |